1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
1 of 3
FEATURED COMPANIES
- Acelity L.P. Inc.
- Adept Medical Ltd
- Invacare Corporation
- MLM Biologics Inc
- Montana State University
- Otivio AS
- MORE
Negative Pressure Wound Therapy (NPWT) - Medical Devices Pipeline Assessment, 2018
Summary
The author's Medical Devices sector report, “Negative Pressure Wound Therapy (NPWT) - Medical Devices Pipeline Assessment, 2018" provides an overview of Negative Pressure Wound Therapy (NPWT) currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Negative Pressure Wound Therapy (NPWT) pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
The report enables you to:
Summary
The author's Medical Devices sector report, “Negative Pressure Wound Therapy (NPWT) - Medical Devices Pipeline Assessment, 2018" provides an overview of Negative Pressure Wound Therapy (NPWT) currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Negative Pressure Wound Therapy (NPWT) pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Negative Pressure Wound Therapy (NPWT) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Negative Pressure Wound Therapy (NPWT) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry.
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Negative Pressure Wound Therapy (NPWT) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date.
Note: Product cover images may vary from those shown
2 of 3
FEATURED COMPANIES
- Acelity L.P. Inc.
- Adept Medical Ltd
- Invacare Corporation
- MLM Biologics Inc
- Montana State University
- Otivio AS
- MORE
1 Table of Contents
2 Introduction
2.1 Negative Pressure Wound Therapy (NPWT) Overview
3 Products under Development
3.1 Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Stage of Development
3.2 Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Territory
3.3 Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Regulatory Path
3.4 Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Estimated Approval Date
4 Negative Pressure Wound Therapy (NPWT) - Pipeline Products under Development by Companies
4.1 Negative Pressure Wound Therapy (NPWT) Companies - Pipeline Products by Stage of Development
4.2 Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Stage of Development
5 Negative Pressure Wound Therapy (NPWT) Companies and Product Overview
5.1 Acelity L.P. Inc. Company Overview
5.1.1 Acelity L.P. Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.2 Adept Medical Ltd Company Overview
5.2.1 Adept Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.3 Applied Tissue Technologies LLC Company Overview
5.3.1 Applied Tissue Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.4 Invacare Corporation Company Overview
5.4.1 Invacare Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.5 MLM Biologics Inc Company Overview
5.5.1 MLM Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Montana State University Company Overview
5.6.1 Montana State University Pipeline Products & Ongoing Clinical Trials Overview
5.7 Otivio AS Company Overview
5.7.1 Otivio AS Pipeline Products & Ongoing Clinical Trials Overview
5.8 Shieldheart Medtech AB Company Overview
5.8.1 Shieldheart Medtech AB Pipeline Products & Ongoing Clinical Trials Overview
5.9 Smith & Nephew Plc Company Overview
5.9.1 Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview
5.10 University of Pisa Company Overview
5.10.1 University of Pisa Pipeline Products & Ongoing Clinical Trials Overview
5.11 Wake Forest Baptist Medical Center Company Overview
5.11.1 Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.12 Worldwide Innovative Healthcare, Inc. Company Overview
5.12.1 Worldwide Innovative Healthcare, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6 Negative Pressure Wound Therapy (NPWT) - Recent Developments
6.1 May 17, 2018: NanoVibronix Provides Business Update for the First Quarter 2018
6.2 May 08, 2018: Sonoma Pharmaceuticals Names Marc Umscheid Chief Operating Officer
6.3 May 08, 2018: Smith & Nephew: Change of Directorate
6.4 May 07, 2018: Invacare Reports Results for First Quarter 2018
6.5 May 03, 2018: Smith & Nephew First Quarter 2018 Trading Report
6.6 May 03, 2018: Cardinal Health Announces Third-quarter Results for Fiscal Year 2018
6.7 May 01, 2018: One Call Partners with Acelity to Improve Patient Adherence to Advanced Wound Therapy
6.8 Apr 25, 2018: New Meta-analysis Demonstrates the Effectiveness of PICO NPWT in Helping to Prevent Surgical Site Complications versus Standard Care
6.9 Apr 04, 2018: Namal Nawana appointed Chief Executive Officer of Smith & Nephew
6.10 Apr 02, 2018: NanoVibronix Provides Year-End 2017 Business Update and Files 10-K
6.11 Mar 20, 2018: Governor Abbott Announces Smith & Nephew Adding New Jobs In Fort Worth
6.12 Mar 01, 2018: Smith & Nephew: Change in Directorate
6.13 Feb 22, 2018: Invacare Appoints Kathleen Leneghan Chief Financial Officer
6.14 Feb 08, 2018: Smith & Nephew Fourth Quarter Trading and Full Year 2017 Results
6.15 Feb 08, 2018: Cardinal Health Reports Second-quarter Results for Fiscal Year 2018
6.16 Feb 07, 2018: Smith & Nephew announces European launch of new PICO 7 Single Use Negative Pressure Wound Therapy System
6.17 Feb 07, 2018: Cardinal Health Adds Akhil Johri to its Board of Directors
6.18 Feb 07, 2018: Invacare Corporation Announces Financial Results for the Fourth Quarter and Full Year Ended December 31, 2017
6.19 Feb 07, 2018: Sonoma Pharmaceuticals Reports Record Total Revenue of $4.8 million for Third Quarter FY 2018 with Year over Year Product Revenue Growth of 46%
6.20 Jan 31, 2018: Smith & Nephew Appoints Roland Diggelmann As Non-Executive Director
6.21 Jan 31, 2018: Appointment of Roland Diggelmann as Non-Executive Director
6.22 Jan 25, 2018: Lohmann & Rauscher: Personnel Change in Executive Board of L&R
6.23 Dec 21, 2017: NanoVibronix CEO Brian Murphy Provides Business Update Letter to Shareholders
6.24 Dec 07, 2017: Invacare Announces North America Reduction in Force as Part of Continued Cost Realignment
6.25 Nov 27, 2017: New Independent Study Results Add to Growing Body of Evidence That PREVENA Therapy Helps Reduce Surgical Site Infections and Complications
6.26 Nov 09, 2017: Sonoma Pharmaceuticals Reports Robust Top Line Growth for Second Quarter FY 2018 with 61% Product Revenue Growth and Total Revenue of $4.3 Million
6.27 Nov 07, 2017: Invacare Reports Results for Third Quarter 2017
6.28 Nov 06, 2017: Cardinal Health Reports First-quarter Results for Fiscal Year 2018
6.29 Nov 06, 2017: Cardinal Health Outlines Leadership Succession Plan
6.30 Nov 03, 2017: Smith & Nephew Third Quarter 2017 Trading Report
6.31 Nov 02, 2017: Invacare Announces Departure of Chief Financial Officer
6.32 Oct 25, 2017: New microbiology laboratory enables effective development of antimicrobial wound dressings
6.33 Oct 09, 2017: Smith & Nephew: Notice of Chief Executive Officer’s intention to retire by end of 2018
6.34 Oct 09, 2017: Notice of Chief Executive Officer’s intention to retire by end of 2018
6.35 Oct 02, 2017: Smith & Nephew Announces Directorate Change
6.36 Oct 01, 2017: Molnlycke to establish R&D innovation unit in AstraZeneca’s BioVentureHub
6.37 Sep 18, 2017: Smith & Nephew Announces Change in Board of Directors
6.38 Sep 12, 2017: Smith & Nephew: Appointment of Marc Owen as Non-Executive Director
6.39 Aug 21, 2017: PREVENA Incision Management System Shown to Reduce Incisional Pain and Associated Narcotic Use Among Obese Study Patients Undergoing Cesarean Delivery
6.40 Aug 21, 2017: Invacare Appoints Barbara Bodem to Board of Directors
6.41 Aug 08, 2017: Sonoma Pharmaceuticals Reports Financial Results for First Quarter of Fiscal Year 2018
6.42 Aug 07, 2017: Invacare Reports Results for Second Quarter 2017
6.43 Aug 02, 2017: Cardinal Health Reports Q4 and Fiscal 2017 Results, Provides 2018 Guidance
6.44 Jul 27, 2017: Smith & Nephew Second Quarter and First Half 2017 Results
6.45 Jul 04, 2017: Appointment of Angie Risley as Non-Executive Director and Chairman Elect of the Remuneration Committee
6.46 Jun 26, 2017: Invacare Announces Closure of China Manufacturing Facility in Line with Strategic Transformation
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer
List of Tables
Table 1: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Stage of Development
Table 2: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Territory
Table 3: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Regulatory Path
Table 4: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Estimated Approval Date
Table 5: Negative Pressure Wound Therapy (NPWT) Companies - Pipeline Products by Stage of Development
Table 6: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Stage of Development
Table 7: Acelity L.P. Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 8: Negative Pressure Regenerative Medicine - Chronic Wounds - Product Status
Table 9: Negative Pressure Regenerative Medicine - Chronic Wounds - Product Description
Table 10: Negative Pressure Regenerative Medicine - Hard Tissue - Product Status
Table 11: Negative Pressure Regenerative Medicine - Hard Tissue - Product Description
Table 12: Adept Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Wound Pressure Device - Product Status
Table 14: Wound Pressure Device - Product Description
Table 15: Applied Tissue Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Next Generation Negative Pressure Wound Therapy Device - Product Status
Table 17: Next Generation Negative Pressure Wound Therapy Device - Product Description
Table 18: Invacare Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Negative-Pressure Wound Therapy System - Product Status
Table 20: Negative-Pressure Wound Therapy System - Product Description
Table 21: MLM Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Wound Matrix - Negative Pressure Wound Therapy - Product Status
Table 23: Wound Matrix - Negative Pressure Wound Therapy - Product Description
Table 24: Montana State University Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Tissue Cooling Negative Pressure Wound Therapy System - Product Status
Table 26: Tissue Cooling Negative Pressure Wound Therapy System - Product Description
Table 27: Otivio AS Pipeline Products & Ongoing Clinical Trials Overview
Table 28: FlowOx - Next Version - Product Status
Table 29: FlowOx - Next Version - Product Description
Table 30: Shieldheart Medtech AB Pipeline Products & Ongoing Clinical Trials Overview
Table 31: ShieldHeart Protection Device - Product Status
Table 32: ShieldHeart Protection Device - Product Description
Table 33: Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 34: RENASYS TOUCH Connect - Product Status
Table 35: RENASYS TOUCH Connect - Product Description
Table 36: University of Pisa Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Smart Wearable And Autonomous Negative Pressure Device - Product Status
Table 38: Smart Wearable And Autonomous Negative Pressure Device - Product Description
Table 39: Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Mechanical Tissue Resuscitation Device - Product Status
Table 41: Mechanical Tissue Resuscitation Device - Product Description
Table 42: Worldwide Innovative Healthcare, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Wound-Pump - Product Status
Table 44: Wound-Pump - Product Description
Table 45: Glossary
List of Figures
Figure 1: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Stage of Development
Figure 2: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Territory
Figure 3: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Regulatory Path
Figure 4: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Estimated Approval Date 9
2 Introduction
2.1 Negative Pressure Wound Therapy (NPWT) Overview
3 Products under Development
3.1 Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Stage of Development
3.2 Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Territory
3.3 Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Regulatory Path
3.4 Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Estimated Approval Date
4 Negative Pressure Wound Therapy (NPWT) - Pipeline Products under Development by Companies
4.1 Negative Pressure Wound Therapy (NPWT) Companies - Pipeline Products by Stage of Development
4.2 Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Stage of Development
5 Negative Pressure Wound Therapy (NPWT) Companies and Product Overview
5.1 Acelity L.P. Inc. Company Overview
5.1.1 Acelity L.P. Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.2 Adept Medical Ltd Company Overview
5.2.1 Adept Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.3 Applied Tissue Technologies LLC Company Overview
5.3.1 Applied Tissue Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.4 Invacare Corporation Company Overview
5.4.1 Invacare Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.5 MLM Biologics Inc Company Overview
5.5.1 MLM Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Montana State University Company Overview
5.6.1 Montana State University Pipeline Products & Ongoing Clinical Trials Overview
5.7 Otivio AS Company Overview
5.7.1 Otivio AS Pipeline Products & Ongoing Clinical Trials Overview
5.8 Shieldheart Medtech AB Company Overview
5.8.1 Shieldheart Medtech AB Pipeline Products & Ongoing Clinical Trials Overview
5.9 Smith & Nephew Plc Company Overview
5.9.1 Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview
5.10 University of Pisa Company Overview
5.10.1 University of Pisa Pipeline Products & Ongoing Clinical Trials Overview
5.11 Wake Forest Baptist Medical Center Company Overview
5.11.1 Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.12 Worldwide Innovative Healthcare, Inc. Company Overview
5.12.1 Worldwide Innovative Healthcare, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6 Negative Pressure Wound Therapy (NPWT) - Recent Developments
6.1 May 17, 2018: NanoVibronix Provides Business Update for the First Quarter 2018
6.2 May 08, 2018: Sonoma Pharmaceuticals Names Marc Umscheid Chief Operating Officer
6.3 May 08, 2018: Smith & Nephew: Change of Directorate
6.4 May 07, 2018: Invacare Reports Results for First Quarter 2018
6.5 May 03, 2018: Smith & Nephew First Quarter 2018 Trading Report
6.6 May 03, 2018: Cardinal Health Announces Third-quarter Results for Fiscal Year 2018
6.7 May 01, 2018: One Call Partners with Acelity to Improve Patient Adherence to Advanced Wound Therapy
6.8 Apr 25, 2018: New Meta-analysis Demonstrates the Effectiveness of PICO NPWT in Helping to Prevent Surgical Site Complications versus Standard Care
6.9 Apr 04, 2018: Namal Nawana appointed Chief Executive Officer of Smith & Nephew
6.10 Apr 02, 2018: NanoVibronix Provides Year-End 2017 Business Update and Files 10-K
6.11 Mar 20, 2018: Governor Abbott Announces Smith & Nephew Adding New Jobs In Fort Worth
6.12 Mar 01, 2018: Smith & Nephew: Change in Directorate
6.13 Feb 22, 2018: Invacare Appoints Kathleen Leneghan Chief Financial Officer
6.14 Feb 08, 2018: Smith & Nephew Fourth Quarter Trading and Full Year 2017 Results
6.15 Feb 08, 2018: Cardinal Health Reports Second-quarter Results for Fiscal Year 2018
6.16 Feb 07, 2018: Smith & Nephew announces European launch of new PICO 7 Single Use Negative Pressure Wound Therapy System
6.17 Feb 07, 2018: Cardinal Health Adds Akhil Johri to its Board of Directors
6.18 Feb 07, 2018: Invacare Corporation Announces Financial Results for the Fourth Quarter and Full Year Ended December 31, 2017
6.19 Feb 07, 2018: Sonoma Pharmaceuticals Reports Record Total Revenue of $4.8 million for Third Quarter FY 2018 with Year over Year Product Revenue Growth of 46%
6.20 Jan 31, 2018: Smith & Nephew Appoints Roland Diggelmann As Non-Executive Director
6.21 Jan 31, 2018: Appointment of Roland Diggelmann as Non-Executive Director
6.22 Jan 25, 2018: Lohmann & Rauscher: Personnel Change in Executive Board of L&R
6.23 Dec 21, 2017: NanoVibronix CEO Brian Murphy Provides Business Update Letter to Shareholders
6.24 Dec 07, 2017: Invacare Announces North America Reduction in Force as Part of Continued Cost Realignment
6.25 Nov 27, 2017: New Independent Study Results Add to Growing Body of Evidence That PREVENA Therapy Helps Reduce Surgical Site Infections and Complications
6.26 Nov 09, 2017: Sonoma Pharmaceuticals Reports Robust Top Line Growth for Second Quarter FY 2018 with 61% Product Revenue Growth and Total Revenue of $4.3 Million
6.27 Nov 07, 2017: Invacare Reports Results for Third Quarter 2017
6.28 Nov 06, 2017: Cardinal Health Reports First-quarter Results for Fiscal Year 2018
6.29 Nov 06, 2017: Cardinal Health Outlines Leadership Succession Plan
6.30 Nov 03, 2017: Smith & Nephew Third Quarter 2017 Trading Report
6.31 Nov 02, 2017: Invacare Announces Departure of Chief Financial Officer
6.32 Oct 25, 2017: New microbiology laboratory enables effective development of antimicrobial wound dressings
6.33 Oct 09, 2017: Smith & Nephew: Notice of Chief Executive Officer’s intention to retire by end of 2018
6.34 Oct 09, 2017: Notice of Chief Executive Officer’s intention to retire by end of 2018
6.35 Oct 02, 2017: Smith & Nephew Announces Directorate Change
6.36 Oct 01, 2017: Molnlycke to establish R&D innovation unit in AstraZeneca’s BioVentureHub
6.37 Sep 18, 2017: Smith & Nephew Announces Change in Board of Directors
6.38 Sep 12, 2017: Smith & Nephew: Appointment of Marc Owen as Non-Executive Director
6.39 Aug 21, 2017: PREVENA Incision Management System Shown to Reduce Incisional Pain and Associated Narcotic Use Among Obese Study Patients Undergoing Cesarean Delivery
6.40 Aug 21, 2017: Invacare Appoints Barbara Bodem to Board of Directors
6.41 Aug 08, 2017: Sonoma Pharmaceuticals Reports Financial Results for First Quarter of Fiscal Year 2018
6.42 Aug 07, 2017: Invacare Reports Results for Second Quarter 2017
6.43 Aug 02, 2017: Cardinal Health Reports Q4 and Fiscal 2017 Results, Provides 2018 Guidance
6.44 Jul 27, 2017: Smith & Nephew Second Quarter and First Half 2017 Results
6.45 Jul 04, 2017: Appointment of Angie Risley as Non-Executive Director and Chairman Elect of the Remuneration Committee
6.46 Jun 26, 2017: Invacare Announces Closure of China Manufacturing Facility in Line with Strategic Transformation
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer
List of Tables
Table 1: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Stage of Development
Table 2: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Territory
Table 3: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Regulatory Path
Table 4: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Estimated Approval Date
Table 5: Negative Pressure Wound Therapy (NPWT) Companies - Pipeline Products by Stage of Development
Table 6: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Stage of Development
Table 7: Acelity L.P. Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 8: Negative Pressure Regenerative Medicine - Chronic Wounds - Product Status
Table 9: Negative Pressure Regenerative Medicine - Chronic Wounds - Product Description
Table 10: Negative Pressure Regenerative Medicine - Hard Tissue - Product Status
Table 11: Negative Pressure Regenerative Medicine - Hard Tissue - Product Description
Table 12: Adept Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Wound Pressure Device - Product Status
Table 14: Wound Pressure Device - Product Description
Table 15: Applied Tissue Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Next Generation Negative Pressure Wound Therapy Device - Product Status
Table 17: Next Generation Negative Pressure Wound Therapy Device - Product Description
Table 18: Invacare Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Negative-Pressure Wound Therapy System - Product Status
Table 20: Negative-Pressure Wound Therapy System - Product Description
Table 21: MLM Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Wound Matrix - Negative Pressure Wound Therapy - Product Status
Table 23: Wound Matrix - Negative Pressure Wound Therapy - Product Description
Table 24: Montana State University Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Tissue Cooling Negative Pressure Wound Therapy System - Product Status
Table 26: Tissue Cooling Negative Pressure Wound Therapy System - Product Description
Table 27: Otivio AS Pipeline Products & Ongoing Clinical Trials Overview
Table 28: FlowOx - Next Version - Product Status
Table 29: FlowOx - Next Version - Product Description
Table 30: Shieldheart Medtech AB Pipeline Products & Ongoing Clinical Trials Overview
Table 31: ShieldHeart Protection Device - Product Status
Table 32: ShieldHeart Protection Device - Product Description
Table 33: Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 34: RENASYS TOUCH Connect - Product Status
Table 35: RENASYS TOUCH Connect - Product Description
Table 36: University of Pisa Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Smart Wearable And Autonomous Negative Pressure Device - Product Status
Table 38: Smart Wearable And Autonomous Negative Pressure Device - Product Description
Table 39: Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Mechanical Tissue Resuscitation Device - Product Status
Table 41: Mechanical Tissue Resuscitation Device - Product Description
Table 42: Worldwide Innovative Healthcare, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Wound-Pump - Product Status
Table 44: Wound-Pump - Product Description
Table 45: Glossary
List of Figures
Figure 1: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Stage of Development
Figure 2: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Territory
Figure 3: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Regulatory Path
Figure 4: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Estimated Approval Date 9
Note: Product cover images may vary from those shown
3 of 3
LOADING...
4 of 3
- Acelity L.P. Inc.
- Adept Medical Ltd
- Applied Tissue Technologies LLC
- Invacare Corporation
- MLM Biologics Inc
- Montana State University
- Otivio AS
- Shieldheart Medtech AB
- Smith & Nephew Plc
- University of Pisa
- Wake Forest Baptist Medical Center
- Worldwide Innovative Healthcare, Inc
Note: Product cover images may vary from those shown
